Petros Pharmaceuticals Inc (PTPI) concluded trading on Thursday at a closing price of $0.05, with 3.85 million shares of worth about $0.19 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -85.66% during that period and on April 10, 2025 the price saw a loss of about -8.11%. Currently the company’s common shares owned by public are about 53.52M shares, out of which, 43.80M shares are available for trading.
Stock saw a price change of -30.51% in past 5 days and over the past one month there was a price change of -48.20%. Year-to-date (YTD), PTPI shares are showing a performance of -87.92% which decreased to -94.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.05 but also hit the highest price of $0.94 during that period. The average intraday trading volume for Petros Pharmaceuticals Inc shares is 35.63 million. The stock is currently trading -36.31% below its 20-day simple moving average (SMA20), while that difference is down -64.10% for SMA50 and it goes to -84.00% lower than SMA200.
Petros Pharmaceuticals Inc (NASDAQ: PTPI) currently have 53.52M outstanding shares and institutions hold larger chunk of about 1.82% of that.
The stock has a current market capitalization of $2.55M and its 3Y-monthly beta is at 2.13. It has posted earnings per share of -$3.62 in the same period. It has Quick Ratio of 0.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PTPI, volatility over the week remained 19.11% while standing at 21.92% over the month.
